Doctor explains why some experienced severe side effects from semaglutide injections

Doctor explains why some experienced severe side effects from semaglutide injections

Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER visit. Raja says not to order semaglutide online and its good to talk to your doctor to see if it may be right for you.

Doctors Warn About Startling New Ozempic Side Effect That Causes a "Prematurely Aged Appearance"

As with any weight-loss regimen, changes in physical appearance are expected. However, for those using weight-loss injections like Ozempic, some aesthetic side effects are more rattling than others. In fact, semaglutide has elicited its own subset of startling aftereffects, such as "Ozempic face," "Ozempic feet," and most recently, "Ozempic mouth." "With such rapid weight loss, we're increasingly seeing aesthetic side effects," said doctor Ed Ro…

Semaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial shows

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). The interim results also reveal meaningful weight loss and improved cardiometabolic markers, with a favorable safety profile.

This drug could reverse advanced liver disease, study finds

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can significantly improve—and in some cases even reverse—advanced liver disease. The findings come from the ESSENCE Phase III clinical trial, the first large-scale, regulatory-level study to show clear benefits of semaglutide in treating metabolic dysfunction-associated steatohepatitis […] The post This drug could reverse advanced li…

ESSENCE: Semaglutide effectively treats liver disease in two thirds of patients

Results from the ESSENCE Phase III clinical trial show treating patients with semaglutide can halt and even reverse liver disease, the first regulatory-level trial showing the benefit of semaglutide for people with MASH.The placebo-controlled outcome trial of participants with metabolic dysfunction associated steatohepatitis (MASH) was conducted at 253 clinical sites across 37 countries around the world. The trial is led by two chief investigato…